insights_auto
Why is CSBR down 2.72%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
US$4.65
arrow_downward
-2.72%(-0.13) 1D
ኖቬም 12, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4.64
High
US$4.70
Low
US$4.60
Mkt. cap
64.72 ሚ
Avg. vol.
8.11 ሺ
Volume
3.99 ሺ
52-wk high
US$8.31
52-wk low
US$4.60
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Open
US$4.64
High
US$4.70
Low
US$4.60
Mkt. cap
64.72 ሚ
Avg. vol.
8.11 ሺ
Volume
3.99 ሺ
52-wk high
US$8.31
52-wk low
US$4.60
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
TV News Check
·
ከ8 ደቂቃዎች በፊት
Dow Dips 189, Nasdaq Sinks 100, S&P 500 Falls 27
Investing.com
·
ከ57 ደቂቃዎች በፊት
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.36%
Yahoo Finance
·
ከ1 ሰዓት በፊት
S&P 500 Recovered $1 Trillion in 90 Minutes Despite Wider Market Crash
Traders Union
·
ከ31 ደቂቃዎች በፊት
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com